Back to search

Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer

Data up to Jan 2025

Published1996
Citations67
References24

Total Citations Per Year

Abstract

References (24)

Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors

1976 • 1,617 citations

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors

2016 • 1,466 citations

Cancer statistics, 1995

1995 • 1,434 citations

Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors

1976 • 978 citations

Carcinoma in situ.

1992 • 292 citations

LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

1992 • 285 citations

COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY

1992 • 231 citations

Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year Followup

1992 • 210 citations

A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?

1991 • 179 citations

A Randomized Controlled Study of Intravesical α−2b-Interferon in Carcinoma in Situ of the Bladder

1990 • 171 citations

Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.

1988 • 154 citations

Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder

1995 • 123 citations

Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin Therapy

1994 • 114 citations

Original Articles

1995 • 92 citations

BCG in Perspective: Advances in the Treatment of Superficial Bladder Cancer

1995 • 69 citations

Improving the Efficacy of BCG Immunotherapy by Dose Reduction

1995 • 66 citations

Improving the Safety of BCG Immunotherapy by Dose Reduction

1995 • 49 citations

Antiproliferative effects of bacillus Calmette-Gu�rin and interferon ?2b on human bladder cancer cells in vitro

1995 • 44 citations

Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer

1995 • 34 citations

Intravesical interferon alfa in the treatment of superficial bladder cancer

1988 • 15 citations

High-dose versus low-dose intravesical interferon-α2b in the treatment of carcinoma in situ

1992 • 12 citations

Prospective, randomized trial to evaluate high-versus low-dose interferon-α2b versus conventional chemotherapy in prevention of the recurrence of superficial transitional cell carcinoma of the urinary bladder

1992 • 7 citations

Intravesical interferon alfa in the treatment of superficial bladder cancer.

1988 • 5 citations

Is a Prediction of Negative Margins and Continence Possible before Radical Prostatectomy?

1995 • 3 citations

Cited By (0)

Loading...
Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with… (1996) – Urology | Metascience Observatory Explorer